• Cardiovascular health
Serving Size: 1 Capsule... %DV
Vitamin B6 (as Pyridoxal-5'-phosphate)... 17 mg... 850%
Folic acid... 267 mcg... 67%
(as calcium L-5-MTHF)
Vitamin B12 (as Methylcobalamin)... 216 mcg... 3600%
Trimethylglycine (betaine anhydrous) 500 mg... †
†Daily Value not established
What Is It?
Methylation is not a commonly discussed topic in health circles; however, proper methylation processes are the basis for health in so many areas. Without adequately functioning methylation, aging and disease arrive quickly. Homocysteine is a byproduct of the methylation cycle. The enzymes that metabolize homocysteine into methionine and cysteine use folate, vitamin B12, and vitamin B6 as cofactors. Trimethylglycine is one of the most important methylating agents and homocysteine-lowering substances known.
What Does It Do?
Primary Uses: High homocysteine is an indicator of increased risk of heart disease. MaxMethyl is formulated to include all the cofactors and methyl donors needed to convert homocysteine into useful amino acids, thereby helping to reduce the risk of heart disease. The combination of ingredients used in MaxMethyl was shown to significantly reduce homocysteine levels after just 6 weeks of supplementation. Trimethylglycine can reduce homocysteine plasma levels by as much as 30%. B vitamins, specifically B6, B12 and folate, have been shown to reduce the risk of stroke by reducing homocysteine levels.
Secondary Uses: High homocysteine levels have also been implicated in bone loss, joint degradation, mood imbalances, cognitive disorders and other common conditions.
Who Should Take It?
Most people do not get enough of the specific nutrients that support methylation in their diets. MaxMethyl is an excellent supplement for aging in general, for those with high homocysteine levels, and those looking for support against age-related degenerative conditions of the bones, joints, nerves and cognitive function.
Take 1 capsule three times daily with/without food, or as directed by a qualified health care practitioner.
Cashman KD. Homocysteine and osteoporotic fracture risk: a potential role for B vitamins. Nutr Rev. 2005 Jan;63(1):29-36.
Herrmann M, Widmann T, Herrmann W. Homocysteine – a newly recognised risk factor for osteoporosis. Clin Chem Lab Med. 2005;43(10):1111-7
Jellin JM, Gregory P, Batz F, Hitchens K, et al. Pharmacist's Letter/Prescriber's Letter Natural Medicines Comprehensive Database. 3rd ed. Stockton, CA: Therapeutic Research Faculty; 2000
Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine as a predictive factor for hip fracture in stroke patients. Bone. 2005 Apr;36(4):721-6.
Shils M. E., Olson J.A., Shike M., Ross A. C., Modern Nutrition in Health and Disease, 1998, 9th Edition, Baltimore, Lippincott Williams & Wilkins
Verhoef P, de Groot LC. Dietary determinants of plasma homocysteine concentrations. Semin Vasc Med. 2005 May;5(2):110-23. Review.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.